Table 4 Patient distribution (n) between proposed IASLC/ITMIG stages and Masaoka-Koga classification
From: Evaluation of the new TNM-staging system for thymic malignancies: impact on indication and survival
IASLC/ITMIG stages | Total | |||||||
|---|---|---|---|---|---|---|---|---|
I | II | IIIa | IIIb | IVa | IVb | |||
Masaoka-Koga | I | 9 | 0 | 0 | 0 | 0 | 0 | 9 |
IIa | 6 | 0 | 0 | 0 | 0 | 0 | 6 | |
IIb | 8 | 0 | 0 | 0 | 0 | 0 | 8 | |
III | 0 | 1 | 15 | 2 | 2 | 0 | 20 | |
IVa | 0 | 0 | 0 | 0 | 28 | 0 | 28 | |
IVb | 0 | 0 | 0 | 0 | 0 | 5 | 5 | |
Total | 23 | 1 | 15 | 2 | 30 | 5 | 76 | |